Gao Die, Zhang Yonglan, Yang Fengqing, Lin Yexin, Zhang Qihui, Xia Zhining
Department of Pharmacy, College of Chemistry and Chemical Engineering, Chongqing University, Chongqing 400030, P.R. China.
Pharmacogn Mag. 2016 Apr-Jun;12(46):120-7. doi: 10.4103/0973-1296.177909.
Peroxisome proliferator-activated receptors (PPAR)-γ is widely used as an attractive target for the treatment of type 2 diabetes mellitus. Thiazolidinediones, the agonists of PPARγ, has been popularly utilized as insulin sensitizers in the therapy of type 2 diabetes whereas numerous severe side-effects may also occur concomitantly.
The PPARγ activation activity of different polar extracts, including petroleum ether, ethyl acetate, n-butanol, residual of ethanol, the precipitate part of water and the supernatant of water extracts, from 37 traditional Chinese medicines were systematically evaluated.
HeLa cells were transiently co-transfected with the re-constructed plasmids of GAL4-PPARγ-ligand binding domain and pGL4.35. The activation of PPARγ by different polarity extracts were evaluated based on the PPARγ transactivation assay and rosiglitazone was used as positive control.
Seven medicines (root bark of Lycium barbarum, Anoectochilus sroxburghii, the rhizome of Phragmites australis, Pterocephalus hookeri, Polygonatum sibiricum, fruit of Gleditsia sinensis, and Epimedium brevicornu) were able to significantly activate PPARγ.
As seven medicines were able to activate PPARγ, the anti-diabetic activity of them is likely to be mediated by this nuclear receptor.
Lots of the tested medicinal products had activation effects on activating PPARγEthyl acetate extracts of root bark of L.barbarum, rhizome of P.saustralis and fruit of G.siasinensis showed good PPARγ activation effect similar or higher than that of positive control, 0.5 μg/mL rosiglitazonePetroleum ether extracts of A.roxburghii, P. hookeri, P. sibiricum, E.brevicornu also can significantly activate PPARγ, the effects of them were higher than t0.5 μg/mL rosiglitazoneSchisandra chinensis (Turcz.) Baill., the fruit Cornus officinalis Siebold and Zucc., Alisma plantago-aquatica L. and the root of Trichosanthes Kirilowii Maxim., traditional anti-diabetic mediciness in China, had no effects on the activation of PPARγ. Abbreviations used: PPARγ: Peroxisome Proliferator-activated Receptors-γ, TCMs: Traditional Chinese medicines, TZDs: Thiazolidinediones, LBD: Ligand binding domain, DMSO: Dimethyl sulfoxide, FBS: Fetal bovine serum, DMEM: Dulbecco's modified Eagle's medium.
过氧化物酶体增殖物激活受体(PPAR)-γ作为治疗2型糖尿病颇具吸引力的靶点被广泛应用。噻唑烷二酮类药物作为PPARγ激动剂,在2型糖尿病治疗中作为胰岛素增敏剂被广泛使用,但其也可能伴随出现众多严重的副作用。
系统评价37种中药不同极性提取物(石油醚、乙酸乙酯、正丁醇、乙醇残留、水提沉淀部位及水提上清部位)的PPARγ激活活性。
将GAL4-PPARγ-配体结合域重组质粒与pGL4.35瞬时共转染至HeLa细胞。基于PPARγ反式激活试验评价不同极性提取物对PPARγ的激活作用,以罗格列酮作为阳性对照。
7种药物(枸杞根皮、金线莲、芦苇根茎、翼首草、玉竹、皂荚果实、淫羊藿)能够显著激活PPARγ。
由于7种药物能够激活PPARγ,它们的抗糖尿病活性可能由该核受体介导。
许多受试药品对激活PPARγ有作用。枸杞根皮、芦苇根茎和皂荚果实的乙酸乙酯提取物表现出良好的PPARγ激活作用,与阳性对照0.5μg/mL罗格列酮相似或更高。金线莲、翼首草、玉竹、淫羊藿的石油醚提取物也能显著激活PPARγ,其作用高于0.5μg/mL罗格列酮。中国传统抗糖尿病药物五味子、山茱萸、泽泻和瓜蒌根对PPARγ的激活无作用。缩写词:PPARγ:过氧化物酶体增殖物激活受体-γ,TCMs:中药,TZDs:噻唑烷二酮类,LBD:配体结合域,DMSO:二甲基亚砜,FBS:胎牛血清,DMEM:杜氏改良 Eagle培养基。